Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan C Fields

Showing results (281-290 of 344) with videos related to

Pageof 35
Sort By:
Journal of Surgical Oncology|February 18, 2017
The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 yearsCecilia G Ethun, Lauren M Postlewait, Mia R McInnis, et al.
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
JAMA Surgery|October 21, 2016
Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter StudyLauren M Postlewait, Cecilia G Ethun, Mia R McInnis, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancers|April 23, 2022
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted TherapyCatherine G Tran, Luis C Borbon, Jacqueline L Mudd, et al.
Annals of Surgery|January 22, 2015
Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer CollaborativeLinda X Jin, Lindsey E Moses, M Hart Squires, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Science Immunology|August 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancerGraham D Hogg, Alyssa G Weinstein, Natalie L Kingston, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 12, 2017
Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Ezra Lyon, Joe Kearney, et al.
Journal of the American College of Surgeons|April 27, 2016
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic SchemeFabio Bagante, Thuy Tran, Gaya Spolverato, et al.
Pageof 35

Showing results (281-290 of 344) with videos related to

Sort By:
Pageof 35
Journal of Surgical Oncology|February 18, 2017
The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 yearsCecilia G Ethun, Lauren M Postlewait, Mia R McInnis, et al.
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
JAMA Surgery|October 21, 2016
Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter StudyLauren M Postlewait, Cecilia G Ethun, Mia R McInnis, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancers|April 23, 2022
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted TherapyCatherine G Tran, Luis C Borbon, Jacqueline L Mudd, et al.
Annals of Surgery|January 22, 2015
Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer CollaborativeLinda X Jin, Lindsey E Moses, M Hart Squires, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Science Immunology|August 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancerGraham D Hogg, Alyssa G Weinstein, Natalie L Kingston, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 12, 2017
Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Ezra Lyon, Joe Kearney, et al.
Journal of the American College of Surgeons|April 27, 2016
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic SchemeFabio Bagante, Thuy Tran, Gaya Spolverato, et al.
Pageof 35